Biomerica (BMRA) Net Cash Flow Growth (1y) (2011 - 2026)
Biomerica (BMRA) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | 76.43% |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 | -273.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -273.07% |
| Nov 30, 2025 | 35.65% |
| Aug 31, 2025 | 148.51% |
| May 31, 2025 | 37.64% |
| Feb 28, 2025 | 137.81% |
| Nov 30, 2024 | 7.38% |
| Aug 31, 2024 | 22.63% |
| May 31, 2024 | -116.76% |
| Feb 29, 2024 | -6.51% |
| Nov 30, 2023 | 14.60% |
| Aug 31, 2023 | -1,115.79% |
| May 31, 2023 | 250.22% |
| Feb 28, 2023 | -157.30% |
| Nov 30, 2022 | 50.39% |
| Aug 31, 2022 | -78.70% |
| May 31, 2022 | -295.07% |
| Feb 28, 2022 | 833.68% |
| Nov 30, 2021 | -57.61% |
| Aug 31, 2021 | 147.94% |
| May 31, 2021 | -117.19% |